As Mizesaw says, we dangle on the price of oil.
When oil was high and there were hysterical cries of "peak oil", a whole bunch of outfits committed a crapload of expensive equipment to drilling for it at marginal cost advantage,
Now that the price of production exceeds the price per barrel, they bleed or shut down operations. The Saudi's gamble that PB rises and the Saudis cash in.
We are stuck in the middle ground. We glide on the hedges, that seemed so expensive, until they run out. Then it's a question if we can hang on long enough to wait for the price of oil to recover. We borrowed too much to maintain our previously conservative posture, and now we are paying for it.
If the PPB doesn't rise pretty damn soon, our PPS sinks, followed by the distribution, slowed by hedging.
As environmental pressures kick in the fracker's oil will become more expensive.
Can you tell us what the PPB of the frackers and the deep ocean drillers is compared to our own cost of production?
Hi Mizesaw: This is the second down in the mouth stock we've shared.
I would speculate that BBEP's price, being linked to the price of oil, is going to depend on the price of production of shale oil for some time.
We have suffered no definitive clinical trial failures that i know of and the potential still remains alluring.
The mutable nature of cancer demands that any effective treatment will probably consist of combinations of drugs, etc.
PD1 is only 1 of a number of promising checkpoint inhibitors.
We have the cash and low debt to ride this out till our new engines come online.
The fueling infrastructure to support it keeps growing.
The cost per mile advantage continues to hold solidly.
Hunker down and relax.
Short babble Beeny.
We have money in the bank to ride this out as planned.
NG will become the low cost transition fuel of the near future,
and WPRT is positioned to take advantage of that fact.
You sell and i'll happily buy.
The S&P is near it's all time high. Expecting our PPS to depend on that is a bad bet.
Chemo saved my #$%$ from a 95% mortality rate in 1980. It's rude and toxic and all we had until recently.
Cancers mutate rapidly often and immunotherapy has problems keeping up generally, so the long term survival rates tend to be discouraging.
We will need more than single focus immunotherapies to defeat cancer.
Please temper your enthusiasm....grin.
Yup, is it comforting to know we are not alone?
As long as the science hasn't come home, no significant drugs are on the market and our cash flow is negative.....
Expect more of the same.
Get real...NOBODY knows.
You can wish real hard,
and whatever happens will happen anyway.
This is a risky masturbatory exercise.
Having bought at over $5, pre split...This puppy would have to soar wildly to achieve break even.
This is still a story stock and the rate the science is proving out remains glacial.
That none of the big pharmas has put real $ behind us is a strong indicator that our science simply isn't all that strong.
I'm still long, but far from encouraged.
LOL...Never had a stock rise that much! Feel like i'm being teased.
For you petitioners demanding justice...Please understand that western capitalists have a very long history of insultingly screwing the Chinese over, and they remember. Don't expect them to be respectful of our interests.
We bought ADRs, not the actual stock. The mechanism of the ADRs was questionable at least.
So our negotiating position is legally pretty weak.
Scraps; I've had mixed results averaging down.
With ISRG and EBIX, both MF recs, i did quite nicely buying when they were low.
Also true of Apple and ISIS.
OTOH, i really ate it on a couple of Chinese small caps
I think your mentor's generalization doesn't hold.